Showing 561-570 of 21412 results for "".
- Exploring d-Allulose: A Functional Sugar Revolutionizing Insulin Resistance Managementhttps://reachmd.com/news/exploring-d-allulose-a-functional-sugar-revolutionizing-insulin-resistance-management/2475254/Insulin resistance underpins escalating rates of type 2 diabetes and obesity-related complications, yet remains an underaddressed factor in clinical practice, calling for novel dieta
- AI-Driven Tool Flags High Heart Failure Risk in Diabetic Patientshttps://reachmd.com/news/ai-driven-tool-flags-high-heart-failure-risk-in-diabetic-patients/2468515/Researchers at UT Southwestern Medical Center have unveiled a machine learning model designed to identify diabetic patients at elevated risk for heart failure due to a distinct heart condition known as diabetic cardiomyopathy. Published in the European Journal of Heart Failure, this tool
- Researchers Identify Genes and Cell Types That May Have Causal Role in Primary Open-Angle Glaucoma Formationhttps://reachmd.com/news/researchers-identify-genes-and-cell-types-that-may-have-causal-role-in-primary-open-angle-glaucoma-formation/2457229/Although primary open-angle glaucoma (POAG) is the leading cause of blindness in people over the age of 55, there remains no cure for the disease and its biological mechanisms are not well understood. Elevated intraocular pressure (IOP) is a major risk factor for the disease, but many
- Primary Care CGM Linked to Better Diabetes Outcomeshttps://reachmd.com/news/primary-care-cgm-better-diabetes-outcomes/2488409/Key Takeaways Among adults with insulin-treated diabetes, 12-month HbA1c decreased by 0.66 percentage points with primary care–initiated continuous glucose monitoring (95% CI 0.57-0.75) versus 0.17 percentage points without continuous glucose monitoring (95% CI 0.08-0.27), fo
- Gestational Diabetes in England Rose 60% in Five Yearshttps://reachmd.com/news/gestational-diabetes-in-england-rose-60-in-five-years/2488221/Key Takeaways In England, gestational diabetes diagnoses rose from around 8% of pregnancies in 2018 to more than 12% in 2022, a 60% increase over five years. Rates were highest among Asian women at around 23% and among women living in the most deprived areas at aroun
- Diabetic Foot Admissions Rose as Major Amputations Fellhttps://reachmd.com/news/diabetic-foot-admissions-rose-as-major-amputations-fell/2488149/Key Takeaways In a 10-year single-center tertiary-care cohort of hospitalized diabetic foot disease in China, 39% of admissions involved Wagner grade 4-5 lesions, 42% osteomyelitis, 38% peripheral arterial disease, and 19% sepsis at presentation. Admissions rose sign
- From Challenges to Change: Diabetes, Mobility, and Civic Engagementhttps://reachmd.com/news/from-challenges-to-change-diabetes-mobility-and-civic-engagement/2483088/Mobility impairments pose a significant concern for individuals living with diabetes, reverberating beyond physical health to affect civic engagement. A closer look reveals an ongoing issue where these health-related challenges translate into reduced voting participation, highlighting a hea
- Health Canada Approves First Botulinum Toxin Type E for Aesthetic Usehttps://reachmd.com/news/health-canada-approves-first-botulinum-toxin-type-e-for-aesthetic-use/2487591/Health Canada has approved Boey (trenibotulinumtoxinE; Allergan Aesthetics, an AbbVie company) for the temporary improvement in the appearance of moderate-to-severe glabellar lines in adult patients, making it the first approved botulinum neurotoxin serotype E for aesthetic use and the first rapi
- Some Types of HPV May Affect Men's Fertility, New Study Suggestshttps://reachmd.com/news/some-types-of-hpv-may-affect-mens-fertility-new-study-suggests/2467949/Scientists have long considered that the world’s most common sexually transmitted infection, human papillomavirus, or HPV, may be a driver of infertility.Most research about HPV’s potential impact on fertility has focused on women. But in recent years, researchers have increasing
- Finding a Solution for Long COVID, One Cell Type at a Timehttps://reachmd.com/news/finding-a-solution-for-long-covid-one-cell-type-at-a-time/2467482/A 2022 study suggesting that blocking a single molecule could protect against severe illness in COVID-19 has led to a $15 million federal gr